Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Colagiuri

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
International Journal of Obesity (2005)|August 30, 2012
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care--an international randomised controlled trialN R Fuller, S Colagiuri, D Schofield, et al.
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Assessment of kidney function in type 2 diabetesS Chadban, M Howell, S Twigg, et al.
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetesS Chadban, M Howell, S Twigg, et al.
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetesS Chadban, M Howell, S Twigg, et al.
Diabetologia|December 15, 2010
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetesM Alssema, D Vistisen, M W Heymans, et al.
Diabetologia|June 11, 2011
Risk scores for predicting type 2 diabetes: using the optimal toolM Alssema, D Vistisen, M W Heymans, et al.
Diabetologia|December 17, 2009
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert ConsultationR K Simmons, K G M M Alberti, E A M Gale, et al.
Diabetologia|December 22, 2011
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholdsS Zoungas, J Chalmers, T Ninomiya, et al.
Diabetes, Obesity & Metabolism|November 21, 2013
Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trialS van Dieren, A P Kengne, J Chalmers, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
International Journal of Obesity (2005)|August 30, 2012
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care--an international randomised controlled trialN R Fuller, S Colagiuri, D Schofield, et al.
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Assessment of kidney function in type 2 diabetesS Chadban, M Howell, S Twigg, et al.
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetesS Chadban, M Howell, S Twigg, et al.
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetesS Chadban, M Howell, S Twigg, et al.
Diabetologia|December 15, 2010
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetesM Alssema, D Vistisen, M W Heymans, et al.
Diabetologia|June 11, 2011
Risk scores for predicting type 2 diabetes: using the optimal toolM Alssema, D Vistisen, M W Heymans, et al.
Diabetologia|December 17, 2009
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert ConsultationR K Simmons, K G M M Alberti, E A M Gale, et al.
Diabetologia|December 22, 2011
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholdsS Zoungas, J Chalmers, T Ninomiya, et al.
Diabetes, Obesity & Metabolism|November 21, 2013
Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trialS van Dieren, A P Kengne, J Chalmers, et al.
Pageof 9